FDA inspection
Konrad Rejdak, M.D.: FDA inspection ending May 19, 2023
FDA inspection 1206061 · Official Action Indicated (OAI) · Lublin
Key facts
| Inspection ID | 1206061 |
|---|---|
| Firm | Konrad Rejdak, M.D. |
| FEI number | 3025922936 |
| Address | Samodzielny Publiczny Szpital Kliniczny, Ul. Dr. Kazimierza Jaczewskiego 8 |
| City | Lublin |
| Country | Poland |
| Fiscal year | 2023 |
| Inspection end date | May 19, 2023 |
| Classification | Official Action Indicated (OAI) |
| Project area | Bioresearch Monitoring |
| Product type | Biologics |
| Warning letter | 671405 |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data